NASDAQ: RVPH - Reviva Pharmaceuticals Holdings, Inc.

Lønnsomhet i seks måneder: +66.67%
Sektor: Healthcare

Kampanjeplan Reviva Pharmaceuticals Holdings, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.

flere detaljer
The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is based in Cupertino, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2018-10-18
ISIN US76152G1004
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://revivapharma.com
Цена ао 3.83
Prisendring per dag: -3.23% (1.86)
Prisendring per uke: +34.33% (1.34)
Prisendring per måned: +57.89% (1.14)
Prisendring over 3 måneder: +33.33% (1.35)
Prisendring over seks måneder: +66.67% (1.08)
Prisendring per år: -65.05% (5.15)
Prisendring over 3 år: -39.19% (2.96)
Prisendring over 5 år: -82.74% (10.43)
Prisendring over 10 år: 0% (1.8)
Prisendring siden begynnelsen av året: +57.89% (1.14)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 24.9 1
P/E 0 0
EV/EBITDA -1.83 0
Total: 2.63

Effektivitet

Navn Betydning Karakter
ROA, % -165.65 0
ROE, % -686.53 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 10506286070.21 10
Lønnsomhet EPS, % 539836144.2 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 615932 2.72
Armistice Capital, LLC 600000 2.65
Millennium Management LLC 423132 1.87
Geode Capital Management, LLC 171192 0.76
Colony Group LLC 171000 0.75
Group One Trading, L.P. 129301 0.57
EMC Capital Management 123915 0.55
Blackrock Inc. 88690 0.39
GSA Capital Partners LLP 70181 0.31
Belvedere Trading LLC 49501 0.22

ETF Dele, % Lønnsomhet for året, % Utbytte, %
iShares Micro-Cap ETF 0.00604 17.09 1.54048



Veileder Stillingstittel Betaling Fødselsår
Dr. Laxminarayan Bhat Ph.D. Founder, CEO, President & Director 560k 1965 (60 år)
Mr. Narayan Prabhu Chief Financial Officer 412.5k 1972 (53 år)

Adresse: United States, Cupertino. CA, 19925 Stevens Creek Boulevard - åpne i Google maps, åpne Yandex-kart
Nettsted: https://revivapharma.com